EXCLUSIVE INTERVIEW: NeuroScience, Inc. President Ann MacGregor Talks about the New Frontiers in Medicine

L-R: Ibrahim Dabo, Ann MacGregor (President of NeuroScience, Inc) & Dawn Franzmeier (Marketing Manager of NeuroScience, Inc).
L-R: Ibrahim Dabo, Ann MacGregor (President of NeuroScience, Inc) & Dawn Franzmeier (Marketing and Laboratory Testing Product Manager at NeuroScience, Inc.).

NeuroScience, Inc. is a leader in Neuro-Endo-Immune systems and markets strictly to health care providers (HCPs).  Ann MacGregor, president of NeuroScience, Inc., spoke exclusively to Ib’s Blog in an interview about how the organization was founded, ongoing research, supplements to aid treatment, seminars and much more.

Dr. Gottfried Kellermann and his wife, Mieke, started NeuroScience, Inc. to explore neurotransmitters and their impact on the body and over the last two decades, he has developed state-of-the-art laboratory assessments in the fields of immunology, endocrinology, and neurology.

“He started out by looking at what would be an optimal sample taken from the human body that would best give feedback from test results. So he wanted something that was much easier than a sample taken from the spinal cord, [Cerebrospinal fluid] CSF,” MacGregor said.

Dr. Kellermann did a number of experiments and came up with the idea of using urine and then saliva and ran numerous tests in order to come up with ranges for these neurotransmitters, MacGregor said.

Over time, Dr. Kellermann observed and received enough feedback from HCPs, that he was able to update the ranges to provide better specificity, given the broader number of patients reviewed.

“The testing volume increased and many HCPs started to see results from the testing” MacGregor said.

She said the doctors came back to Dr. Kellermann and asked if he could develop natural substances that could be used clinically to help patients with deficient levels demonstrated by the testing.

“And so, he developed a whole line of supplements that help inadequate levels of neurotransmitters,” MacGregor said, adding that from there, Dr. Kellermann started to see that there were gaps in the information coming from the testing.

“So Dr. Kellermann decided to look at some of the other systems of the body,” MacGregor said.

“More and more articles were being published about the Neuro-Endo-Immune System (NEI) and Dr. Kellermann started to hone in on that research.  He wanted to see if there were any relationships between the systems of the body and if patterns would show up with testing.”

"NeuroScience, Inc. represents one of the many entrepreneurial companies working on the new frontiers in medicine." - Ann MacGregor.
"NeuroScience, Inc. represents one of the many entrepreneurial companies working on the new frontiers in medicine." - Ann MacGregor.

MacGregor said Dr. Kellermann learned more about immunology and realized it had never been brought to HCPs in the sense of a practical application for use in their practices to help patients.

This contribution could be very helpful in providing more information for HCPs on their patients’ conditions.

Dr. Kellermann currently reviews every single test result that comes into his company providing the HCPs with the best in quality control of test results, said MacGregor, adding that Dr. Kellermann is able to see how the neurotransmitters and the hormones and the immune system all relate to each other.

MacGregor said providing information to physicians will help inform them about these relationships and why there are certain conditions that their patients have, such as depression, anxiety, and fatigue when they are not getting well. 

In terms of bridging the gap between the research and real world application, MacGregor said, “After we do the research, this cutting edge information is sometimes presented in seminars to get the information out to the HCPs who want and need more and better answers for how to help their patients with broad spectrum conditions.”

On May 8, 2010, NeuroScience held its annual seminar in Bethesda, Maryland. The theme was: “Neuro-Endo-Immunology Approach to Clinical Assessments: The New Medical Paradigm”.

“The goal for the seminars is to disseminate the cutting-edge medical theories to encourage clinical input that can further define and/or prove the theory in an effort to speed up the potential health benefit to the patient,” MacGregor said.

“Cutting-edge science is not taught in medical schools yet. It does not have the extensive clinical trials required to be accepted as fact and often needs greater definition for specific aspects.  We try to get the information out to as many HCPs as possible so they may have additional points of reference to use in their quest to solve difficult cases.”

MacGregor added that the goals of the company are to continue to explore the pathways in the body, developing more depth of knowledge over time, and providing more practical clinical applications for HCPs.

“That is the main initiative that we have, and our research centers on this concept.  The company’s goal for supplements is to create natural supplements that will be accepted for clearance by the [Food and Drug Administration] FDA which is a large project.”

“The goal for the seminars is to disseminate the cutting-edge medical theories to encourage clinical input that can further define and/or prove the theory in an effort to speed up the potential health benefit to the patient,” MacGregor said.
“The goal for the seminars is to disseminate the cutting-edge medical theories to encourage clinical input that can further define and/or prove the theory in an effort to speed up the potential health benefit to the patient,” MacGregor said.

Asked what she would say if she were asked to address a group of physicians, MacGregor said: “I would state that NeuroScience, Inc. represents one of the many entrepreneurial companies working on the new frontiers in medicine, and by exploring these frontiers, the goal is to help as many patients as possible who suffer from conditions that are difficult to alleviate with the medical knowledge that we have today.”

MacGregor said that for today’s current practice, many physicians have not been exposed to this information and by providing this new information based in physical science and biochemistry, they are giving physicians better choices that they can use to better help their patients.

Physicians can take advantage of archived webinars on NeuroScience’s website, www.neuroscienceinc.com.

“There are excellent introduction webinars and advanced topics for those HCPs who have followed the company’s work for many years,” MacGregor said.

“We have a number of venues: the webinars, technical support medical education, and we have an excellent marketing group that has put together excellent brochures with a lot of information.”

Also See:
· About Ibrahim | About Ib’s Blog | Testimonials | Ib’s Blog Home
· Football United: From civil war in Sierra Leone to USA success, football lends a hand (Goal.com interviews its former Africa Editor, Ibrahim Dabo)
· EXCLUSIVE: Associated Black Charities Hosts 25-Year Anniversary Gala, Honors African American Innovators and Role Models in Higher Education, and Projects a Promising Vision of Change for 2020
· EXCLUSIVE INTERVIEW: Maryland Has the Best Public School System in America, Governor Martin O’Malley Tells Ib’s Blog

One Comment

  1. Ibrahim,
    Great to meet you out here and to find you on board with the Neuroscience folks. I have had the pleasure of seeing dramatic results by using NS testing to specifically evaluate neurotransmitter, hormone, and immune system imbalances. They have a great team, superior customer service, and price points that bring contemporary neuroscience into the office of many who otherwise couldn’t afford available testing. I have a page on my site that brings much information together regarding the use of evidence in modern psych interventions: http://www.corepsychblog.com/neuroscience

    Thanks for this excellent note!
    cp

Leave a Reply

Your email address will not be published. Required fields are marked *